or Try an Advanced Search...
    Invalid date chosen. Displaying data for the latest date instead.

    Cancer Treatment Stocks List

    Symbol Grade Name % Change
    IBRX C ImmunityBio, Inc. -1.29
    SLS C SELLAS Life Sciences Group, Inc. -0.68
    HRTX C Heron Therapeutics, Inc. -0.62
    IPHA C Innate Pharma S.A. 5.28
    STRO C Sutro Biopharma, Inc. -3.37
    RNXT C RenovoRx, Inc. -6.16
    INMB C INmune Bio Inc. -2.86
    YMAB C Y-mAbs Therapeutics, Inc. -2.11
    CLDX D Celldex Therapeutics, Inc. -4.33
    IOVA D Iovance Biotherapeutics, Inc. -1.82
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
    Related Stock Lists: Cancer Clinical Medicine Biopharmaceutical Medicine Immune System Immunotherapy Solid Tumors Antineoplastic Drugs Immunology Oncology Antibodies Biotechnology Blastoma Brain Tumor Breast Cancer Cancer Center Cancer Immunotherapy Checkpoint Inhibitor Endometrial Cancer Hematologic Malignancies

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 5.09
    IDNA C iShares Genomics Immunology and Healthcare ETF 4.61
    JFWD D Jacob Funds Inc. Jacob Forward ETF 4.03
    PBE C PowerShares Dynamic Biotech & Genome 2.9
    WDNA D WisdomTree BioRevolution Fund 2.58
    View all Cancer Treatment ETFs...
    Compare ETFs
    Compare CNCR to IDNA Compare IDNA to WDNA Compare JFWD to PBE

        Cancer Treatment Stocks Recent News

        Date Stock Title
        May 17 IBRX How Is The Market Feeling About ImmunityBio?
        May 17 HRTX Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 HRTX Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 17 IBRX Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast
        May 16 IOVA 4 Small-Cap Value Stocks That Could Go Parabolic
        May 15 HRTX FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
        May 15 CLDX Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis
        May 15 IPHA Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress
        May 14 SLS SELLAS Life Sciences GAAP EPS of -$0.21
        May 14 SLS SELLAS Life Sciences Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 14 IPHA Innate Pharma S.A. (IPHA) Q1 2024 Earnings Call Transcript
        May 14 IPHA Innate Pharma reports Q1 results
        May 14 RNXT RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024
        May 14 IPHA Innate Pharma Reports First Quarter 2024 Business Update and Financial Results
        May 13 STRO Sutro Biopharma GAAP EPS of -$0.95, revenue of $13M
        May 13 STRO Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
        May 13 IOVA Iovance Biotherapeutics' Amtagvi: Innovative Therapy, Financial Strain (Rating Downgrade)
        May 13 STRO Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for
        May 13 STRO The past three years for Sutro Biopharma (NASDAQ:STRO) investors has not been profitable
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
        Related Stock Lists: Cancer Clinical Medicine Biopharmaceutical Medicine Immune System Immunotherapy Solid Tumors Antineoplastic Drugs Immunology Oncology Antibodies Biotechnology Blastoma Brain Tumor Breast Cancer Cancer Center Cancer Immunotherapy Checkpoint Inhibitor Endometrial Cancer Hematologic Malignancies
        Cancer Treatment

        Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

        Browse All Tags